Effects of BG9719 (CVT-124), an A1-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure
about
Adenosine receptors and the kidneyAdenosine A(2A) Receptor Antagonists and Parkinson's DiseaseGlomerular tubular balance is suppressed in adenosine type 1 receptor-deficient mice.Role of the extracellular cAMP-adenosine pathway in renal physiology.Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: The EFICA study.Heart failure in 10 years time: focus on pharmacological treatment.Adenosine type 1 receptor antagonists in fluid retaining disorders.Determinants of the creatinine clearance to glomerular filtration rate ratio in patients with chronic kidney disease: a cross-sectional study.Adenosine and kidney function: potential implications in patients with heart failure.Novel pharmacological treatments for heart failure.Combination of drugs acting on the natriuretic system and the renin-angiotensin system in heart failure.Adenosine promotes wound healing and mediates angiogenesis in response to tissue injury via occupancy of A(2A) receptors.Vasopressin antagonists in the management of heart failure.Emerging drugs for acute and chronic heart failure: current and future developments.Low salt intake increases adenosine type 1 receptor expression and function in the rat proximal tubule.Overview of emerging pharmacologic agents for acute heart failure syndromes.Emerging diuretics for the treatment of heart failure.M-atrial natriuretic peptide and nitroglycerin in a canine model of experimental acute hypertensive heart failure: differential actions of 2 cGMP activating therapeutics.Emerging therapies for heart failure: renal mechanisms and effects.Tonapofylline: a selective adenosine-1 receptor antagonist for the treatment of heart failure.Can we prevent or treat renal dysfunction in acute heart failure?Renal neurohormonal regulation in heart failure decompensation.Adenosine, type 1 receptors: role in proximal tubule Na+ reabsorption.An orally active adenosine A1 receptor antagonist, FK838, increases renal excretion and maintains glomerular filtration rate in furosemide-resistant ratsCombined effects of carbonic anhydrase inhibitor and adenosine A1 receptor antagonist on hemodynamic and tubular function in the kidney.Haemodynamic effects of rolofylline in the treatment of patients with heart failure and impaired renal function.Expression of adenosine receptors in the preglomerular microcirculation.Influence of the adenosine A1 receptor on blood pressure regulation and renin release.Acute effect of furosemide on glomerular filtration rate in diastolic dysfunction.A pharmacokinetic/pharmacodynamic model capturing the time course of torasemide-induced diuresis in the dog.An exploratory analysis of the competing effects of aggressive decongestion and high-dose loop diuretic therapy in the DOSE trial.
P2860
Q28253255-8C004F44-B838-4C90-8A7D-EE38887E6B7CQ29346492-73C6069C-BE95-4108-873F-FB6E4CD0527FQ34305475-C1822EDE-B013-4F07-BBED-2339D7094607Q34366508-5DD97FCB-DC97-4DCB-9921-C3FFAC88D67DQ34565386-502D6515-3C66-4F19-A0A8-19C182092836Q34817094-1C8EAA2F-081F-41FF-BDF8-929035871541Q35001005-81E94FC3-0BCB-4438-A606-9ECE3CC7EB75Q35059097-5CEC0687-79C1-48D6-B2ED-1CE5C351B914Q35151913-A88D2B52-F2A4-4E34-9B36-16D35BF2C6EBQ35570949-8D5316C5-B9B7-4BB0-95C7-780397C6C799Q35580130-C9ED7038-E2C3-4613-900F-8E5E3C5B2699Q35747902-20472731-4724-4604-88BE-E8138E17C5B4Q36752115-2982947C-6104-4749-951C-574D9203FD6DQ36758585-5E95715E-0D4C-4347-98E5-43B1C5EC67C2Q36807100-94775830-6D38-404D-94A7-D76262C46A89Q37086309-7B767B07-2728-40F6-BDDF-B712FBD9354BQ37386310-E89B1B65-197C-4DA8-9009-E9DACF41A7E7Q37648508-074729E6-32BF-4811-8A74-F05EB0B90A45Q37783956-6429B8B3-60A2-480E-99D6-F163493083EAQ37784234-E357800A-9200-4800-BCD9-AB6CD33ABE1FQ37873812-1B469BB3-07B7-4107-A4F4-5AD0CB5DEF11Q38219634-ABD0F930-A22E-44FD-ABBD-BF01BB8476BFQ38262814-ED312636-5B36-4673-8409-8DFA3C4C39D1Q41823378-9F699982-6136-4DA8-86A5-19CF54C29791Q42717097-F3C98598-E8DD-47BE-8019-5F96575A1818Q42914818-15993C78-C7B2-417D-84CA-BE014C495669Q44024808-BE80BDF4-1D98-4C38-9B01-77A26B6E1830Q46853125-7ACFC88B-C69D-42C2-95CC-80301CFAA454Q46860315-36C0F723-152A-4A97-AFBC-BA22776C3725Q47852597-411B5015-7024-4514-A8EE-B3B39C85DD49Q50660691-1DC7405B-1B3C-412D-84B4-6BFB02C132BF
P2860
Effects of BG9719 (CVT-124), an A1-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Effects of BG9719 (CVT-124), a ...... with congestive heart failure
@ast
Effects of BG9719 (CVT-124), a ...... with congestive heart failure
@en
Effects of BG9719 (CVT-124), a ...... with congestive heart failure
@nl
type
label
Effects of BG9719 (CVT-124), a ...... with congestive heart failure
@ast
Effects of BG9719 (CVT-124), a ...... with congestive heart failure
@en
Effects of BG9719 (CVT-124), a ...... with congestive heart failure
@nl
prefLabel
Effects of BG9719 (CVT-124), a ...... with congestive heart failure
@ast
Effects of BG9719 (CVT-124), a ...... with congestive heart failure
@en
Effects of BG9719 (CVT-124), a ...... with congestive heart failure
@nl
P2093
P1476
Effects of BG9719 (CVT-124), a ...... with congestive heart failure
@en
P2093
E B Liittschwager
J Marshall
M L Fisher
R Freudenberger
S L Skettino
S S Gottlieb
P356
10.1016/S0735-1097(99)00532-X
P407
P577
2000-01-01T00:00:00Z